43rd Annual J.P. Morgan Healthcare Conference 2025
Logotype for Chemed Corporation

Chemed (CHE) 43rd Annual J.P. Morgan Healthcare Conference 2025 summary

Event summary combining transcript, slides, and related documents.

Logotype for Chemed Corporation

43rd Annual J.P. Morgan Healthcare Conference 2025 summary

10 Jan, 2026

Company history and business structure

  • Originated from a 1971 spinoff, evolving through acquisitions and divestitures to focus on healthcare and plumbing services.

  • Acquired full ownership of VITAS in the early 2000s, maintaining Roto-Rooter as a cash-generating business.

  • Maintains transparency for investors, allowing easy sum-of-the-parts analysis.

  • Both businesses are market leaders with strong cash flow and have been held for over 20 years.

Financial performance and capital allocation

  • Adjusted net income for VITAS grew 10.8% annually, Roto-Rooter 14.4%, and overall 21.7% over 21 years.

  • Share count reduced from 27 million to 15 million, enhancing per-share metrics.

  • $2.5 billion returned to shareholders via dividends and buybacks.

  • No debt and $200 million in cash on the balance sheet.

  • Free cash flow is about $300 million, supporting ongoing investments and buybacks.

Roto-Rooter business update

  • Experienced pandemic-driven demand surge, followed by weaker performance in 2023–2024.

  • Long-term outlook remains optimistic, expecting a return to 4%-6% growth.

  • Cash flow from Roto-Rooter supports other business growth and share repurchases.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more